Pfizer Expanding Use of Prescription Drug Prevnar13 for Adults Over 50
Prescription drug manufacturer Pfizer has applied to the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of the medication Prevnar 13 for those aged 50 and older in the prevention of pneumococcal disease.
Thu, 12/23/2010 - 05:46
Prescription Drug Guide: Manufacturer Takes Similac Formulas Off Shelves
Prescription drug guide announcement: Isomil and Go & Grow are two of the Similac-brand infant formulas being recalled by the manufacturer Abbott. The recall involves approximately five million containers, and is occurring due to potential spoilage with larvae and insect pieces.
Thu, 11/25/2010 - 07:11
Info on Prescription Drugs - Herceptin Approved by FDA
Info on Prescription Drugs - Herceptin, a drug used to help treat cancer of the stomach, has received approval by the FDA. The drug has been designed to be used by patients who suffer from HER2-positive metastatic cancer who have not been administered any other medication for their treatment.
Tue, 10/26/2010 - 04:36
Warning Labels Added to HIV Prescriptions Medication
Warning labels must now appear on the HIV prescriptions medication Invirase to warn patients of a potentially deadly combination when taken with Norvir, another HIV drug. Both drugs are classified as protease inhibitors by the FDA and prevent the HIV viral infection from multiplying.
Mon, 10/25/2010 - 05:01
Drugs References Warning Labels Now Added to Prostate Cancer Medication
The FDA has decided to add drugs references warning labels that detail the potential risks of heart disease and diabetes to patients who use prostate cancer gonadotropin-releasing hormone (GnRH) agonists. In addition to the drug’s generic classification, GnRH drugs are sold as brand names Eligard,, Lupron, Synarel, Trelstar, Vantas, and Zoladex in the U.S
Thu, 10/21/2010 - 03:58
Anticoagulant Prescriptions Drug List Now Includes Pradaxa
The FDA has now added Pradaxa to its prescriptions drug list of blood thinners. Pradaxa, also known by is generic dabigatran, has been developed for those at risk of heart attack or stroke, blood clots and for people with atrial fibrillation, or irregular heartbeat.
Wed, 10/20/2010 - 13:47
Learning About Drugs Rx Recalls
Drugs Rx recalls often occur even after a pharmaceutical company has adhered to stringent guidelines and gained FDA approval. During preliminary approval, the FDA's Center for Drug Evaluation and Research evaluates risks and benefits associated with both OTC and prescription drugs and evaluates the safety based on human and animal data in clinical trials.
Thu, 10/14/2010 - 03:41
Alexza’s Generic Drug Rx Rejected Due to Lung Problems Associated with Drug
Stocks have dropped considerably for drug rx company Alexza, whose pivotal medication AZ-004 was denied approval by the FDA this week. The drug, which contains staccato loxapine to help combat the effects of bipolar disorder and schizophrenia, was designed to be administered with a plastic inhaler.
Tue, 10/12/2010 - 05:16
Meridia Officially Off Market After Sibutramine Linked to Heart Attacks
The list prescription that covers all manner of weight loss drugs looks set to dwindle again for patients seeking pharmaceutical help to banish obesity. Abbott Laboratories announced that it is voluntarily pulling off its promising drug Meridia from the U.S. pharmaceutical market amidst concerns of elevated heart disease side effects. The list prescription drug had been FDA approved for use in 1997.
Mon, 10/11/2010 - 04:30
Reducing Errors in Prescription Medicines
Errors in prescription medicines are unfortunate realities that send more than 1.5 million Americans to the emergency room every year. They can occur because of misunderstandings between similarly pronounced drug names which often get mistaken for each other.
Wed, 10/06/2010 - 03:49 